<?xml version="1.0" encoding="UTF-8"?>
<GaPExchange xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="./dbGaPEx2.1.5.xsd">

<MetaVariables>
	<Submitter/>
	<Method/>
</MetaVariables>
<MetaLinks/>

<Projects>
	<Project/>
</Projects>

<Studies>

<Study source="dbGaP" accession="phs000925.v1.p1" parentStudy="phs000925.v1.p1" createDate="2015-06-01" modDate="2017-03-29">

<Configuration>
	<Data_Provider><![CDATA[
		<table border="1">
		<tr><th>Title</th><th>Name</th><th>Institute</th></tr>
		<tr><td>Principal Investigator</td><td>Ruth Loos, PhD</td><td>The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA</td></tr>
		<tr><td>Principal Investigator</td><td>Erwin Bottinger, MD</td><td>The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA</td></tr>
		<tr><td>Funding Source</td><td>The Andrea and Charles Bronfman Philanthropies</td><td>Icahn School of Medicine at Mount Sinai, New York, NY, USA</td></tr>
		<tr><td>Funding Source</td><td>5 U01 HG006380</td><td>National Institutes of Health, Bethesda, MD, USA</td></tr>
		<tr><td>Funding Source</td><td>5 U01 HG007417</td><td>National Institutes of Health, Bethesda, MD, USA</td></tr>
		</table>
	]]></Data_Provider>
	<StudyNameEntrez>PAGE: IPM BioMe Biobank</StudyNameEntrez>
	<StudyNameReportPage>PAGE: The Charles Bronfman Institute for Personalized Medicine (IPM) BioMe BioBank</StudyNameReportPage>
	<StudyTypes>
		<StudyType>Longitudinal Cohort</StudyType>
	</StudyTypes>
	<Description><![CDATA[
<p>The Institute for Personalized Medicine (IPM) Bio<i>Me</i> Biobank is a consented, EMR-linked medical care setting biorepository of the Mount Sinai Medical Center (MSMC) drawing from a population of over 70,000 inpatients and 800,000 outpatient visits annually. MSMC serves diverse local communities of upper Manhattan, including Central Harlem (86% African American), East Harlem (88% Hispanic Latino), and Upper East Side (88% Caucasian/white) with broad health disparities. IPM Bio<i>Me</i> Biobank populations include 28% African American, 38% Hispanic Latino predominantly of Caribbean origin, 23% Caucasian/White. IPM BioMe Biobank disease burden is reflective of health disparities with broad public health impact. Biobank operations are fully integrated in clinical care processes, including direct recruitment from clinical sites waiting areas and phlebotomy stations by dedicated Biobank recruiters independent of clinical care providers, prior to or following a clinician standard of care visit. Recruitment currently occurs at a broad spectrum of over 30 clinical care sites.</p> <p>This study is part of the Population Architecture using Genomics and Epidemiology (PAGE) study (<a href="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000356.v1.p1">phs000356</a>). </p>]]>
	</Description>
	<StudyInEx><![CDATA[
<p>Study participants of self-reported European Ancestry were not included in the ISMMS PAGE II contribution.</p>]]>
	</StudyInEx>
	<StudyProjects>
		<Project/>
	</StudyProjects>
	<Publications>
		<Publication>
			<Pubmed pmid="21573225"/>
		</Publication>
		<Publication>
			<Pubmed pmid="23446634"/>
		</Publication>
		<Publication>
			<Pubmed pmid="23583978"/>
		</Publication>
		<Publication>
			<Pubmed pmid="23588317"/>
		</Publication>
		<Publication>
			<Pubmed pmid="23743551"/>
		</Publication>
		<Publication>
			<Pubmed pmid="23972371"/>
		</Publication>
		<Publication>
			<Pubmed pmid="24507774"/>
		</Publication>
		<Publication>
			<Pubmed pmid="24507775"/>
		</Publication>
		<Publication>
			<Pubmed pmid="24941081"/>
		</Publication>
		<Publication>
			<Pubmed pmid="25102180"/>
		</Publication>
		<Publication>
			<Pubmed pmid="25282103"/>
		</Publication>
		<Publication>
			<Pubmed pmid="25187575"/>
		</Publication>
		<Publication>
			<Pubmed pmid="25631608"/>
		</Publication>
		<Publication>
			<Pubmed pmid="25673413"/>
		</Publication>
		<Publication>
			<Pubmed pmid="25460205"/>
		</Publication>
		<Publication>
			<Pubmed pmid="25349204"/>
		</Publication>
		<Publication>
			<Pubmed pmid="24723935"/>
		</Publication>
		<Publication>
			<Pubmed pmid="25954398"/>
		</Publication>
		<Publication>
			<Pubmed pmid="25954377"/>
		</Publication>
		<Publication>
			<Pubmed pmid="23743551"/>
		</Publication>
		<Publication>
			<Pubmed pmid="23588317"/>
		</Publication>
		<Publication>
			<Pubmed pmid="22832513"/>
		</Publication>
	</Publications>
	<Diseases>
		<Disease vocab_source="MESH" vocab_term="Cardiovascular Diseases"/>
		<Disease vocab_source="MESH" vocab_term="Obesity"/>
		<Disease vocab_source="MESH" vocab_term="Diabetes Mellitus, Type 2"/>
		<Disease vocab_source="MESH" vocab_term="Glucose"/>
		<Disease vocab_source="MESH" vocab_term="Kidney Failure, Chronic"/>
		<Disease vocab_source="MESH" vocab_term="Cholesterol, HDL"/>
		<Disease vocab_source="MESH" vocab_term="Cholesterol, LDL"/>
		<Disease vocab_source="MESH" vocab_term="Triglycerides"/>
		<Disease vocab_source="MESH" vocab_term="Coronary Disease"/>
		<Disease vocab_source="MESH" vocab_term="Myocardial Infarction"/>
		<Disease vocab_source="MESH" vocab_term="Inflammation"/>
		<Disease vocab_source="MESH" vocab_term="Stroke"/>
		<Disease vocab_source="MESH" vocab_term="Body Height"/>
	</Diseases>
	<Attributions>
		<Header title="Principal Investigator">
			<AttName>Ruth Loos, PhD</AttName>
			<Institution>The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA</Institution>
		</Header>
		<Header title="Principal Investigator">
			<AttName>Erwin Bottinger, MD</AttName>
			<Institution>The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>The Andrea and Charles Bronfman Philanthropies</AttName>
			<Institution>Icahn School of Medicine at Mount Sinai, New York, NY, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>5 U01 HG006380</AttName>
			<Institution>National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>5 U01 HG007417</AttName>
			<Institution>National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
	</Attributions>
	<DisplayPublicSummary>yes</DisplayPublicSummary>
	<StudyURLs>
		<Url name="BioMeTM Biobank Program" url="http://icahn.mssm.edu/research/institutes/ipm/programs/biome-biobank"/>
	</StudyURLs>
	<StudyHistory><![CDATA[
<p>2007 IPM Bio<i>Me</i> Biobank starts recruitment at the Mount Sinai Medical Center<br/> 2010 December: Almost 3,000 Bio<i>Me</i> participants (Africa, European and Hispanic ancestry) were genotyped with the Affymetrix Genome-Wide Human SNP Array 6.0<br/> 2011 August: IPM Bio<i>Me</i> Biobank joins the eMERGE II Network<br/> 2012 November: A total of 23,000 participants have been recruited<br/> 2012 December: An additional ~13,000 Bio<i>Me</i> participants were genotyped using the Illumina HumanOmniExpress BeadChip and the ExomeChip<br/> 2013 June: IPM Bio<i>Me</i> Biobank joins the PAGE II Network<br/> 2015 January: A total of 33,000 participants have been recruited and recruitment continues. </p>]]>
	</StudyHistory>
	<ConsentGroups>
		<ConsentGroup groupNum="0" shortName="NRUP" longName="Subjects did not participate in the study, did not complete a consent document and are included only for the pedigree structure and/or genotype controls, such as HapMap subjects"/>
		<ConsentGroup groupNum="1" shortName="GRU" longName="General Research Use"/>
	</ConsentGroups>
</Configuration>

  <AuthorizedAccess>
    <DacInfo ssDacId="0">
      <DacName>NHGRI</DacName>
      <DacFullName>National Human Genome Research Institute</DacFullName>
      <DacEmail>0</DacEmail>
      <DacPhone></DacPhone>
      <DacUrl></DacUrl>
    </DacInfo>
    <Policy Policy_ID="phs000925.v1.p1_policy" ref_ssDacId="0">
      <DisplayResearchStatement>yes</DisplayResearchStatement>
      <DisplayPublicSummary>yes</DisplayPublicSummary>
      <EmbargoLength>12</EmbargoLength>
      <YearsUntilRenewal>1</YearsUntilRenewal>
      <WeeksCancelRequest>8</WeeksCancelRequest>
      <PdfSupplementReqired>no</PdfSupplementReqired>
      <AcknowledgementText>
        <para>
          http://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000925.v1.p1
        </para>
      </AcknowledgementText>
      <DocumentSet>
        <DataUseCertificate Label="Data Use Certificate" FilePath="https://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000925.v1.p1" FileName=""/>
      </DocumentSet>
    </Policy>
    <ConsentGroups>
      <ParticipantSet groupNum-REF="1">
        <ConsentName>General Research Use</ConsentName>
        <ConsentAbbrev>GRU</ConsentAbbrev>
        <UseLimitation>Use of the data is limited only by the terms of the model Data Use Certification.</UseLimitation>
        <IrbRequired>No</IrbRequired>
      </ParticipantSet>
      <ParticipantSet groupNum-REF="999">
        <ConsentName>Exchange Area</ConsentName>
        <ConsentAbbrev>EA</ConsentAbbrev>
        <UseLimitation></UseLimitation>
        <IrbRequired>No</IrbRequired>
      </ParticipantSet>
    </ConsentGroups>
  </AuthorizedAccess>


</Study>

</Studies>

</GaPExchange>
